Sarepta Therapeutics
SRPT
#4840
Rank
A$3.07 B
Marketcap
A$29.12
Share price
-3.38%
Change (1 day)
4.67%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

P/S ratio for Sarepta Therapeutics (SRPT)

P/S ratio as of August 2026 (TTM): 1.03

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.49. At the end of 2026 the company had a P/S ratio of 0.9599.

P/S ratio history for Sarepta Therapeutics from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20260.9599-5.5%
20251.02-83.35%
20246.10-15.9%
20237.26-40.49%
202212.29.13%
202111.2-55.15%
202024.9-2.22%
201925.5-1.12%
201825.810.75%
201723.3-91.58%
2016276-80.34%
2015> 10002193.16%
201461.313.28%
201354.1146.82%
201221.9918.16%
20112.15-73.42%
20108.10-11.73%
20099.17316.41%
20082.20-73.37%
20078.27-99.44%
2006> 10003874.02%
200536.9-81.29%
200419736.42%
2003145-8.87%
2002159-55.81%
2001359

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Gilead Sciences
GILD
6.05 490.18%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
7.07 589.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
2.47 141.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
7.34 615.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
31.6 2,979.26%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
2.82 175.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
600 58,374.94%๐Ÿ‡บ๐Ÿ‡ธ USA